As a parent of a young man with ASD, I know firsthand about delays in diagnosis and searching for solutions and treatments. We tried many of the well-known interventions — modified diet, dietary supplements, attention deficient medicine — the list goes on and on.
When I founded the company, we built a platform to measure metabolism in cells with a high degree of accuracy. Later we used the platform to specifically identify differences in metabolism that are consistent with an ASD diagnosis.
As the company evolves, we hope to learn more about the role our test plays in the larger precision medicine conversation.